Bismuthyl Ecabet

碱式依卡倍特铋

Report date: 2022/02/28 15:45:22
NME

Base Information

Drug NameBismuthyl Ecabet
Drug Alias Name碱式依卡贝特铋
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsPeptic Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Xingkang Medicine Research Development Co LtdZhuhai Yibang Pharmaceutical Co LtdXing'An Pharmaceutical Co Ltd +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChina Resources Pharmaceutical Group LtdShanghai Xingkang Medicine Research Development Co LtdXing'An Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPeptic Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A